<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font32">inflammatory </span>
   <span class="font30">responses </span>
   <span class="font26">viral </span>
   <span class="font25">lung </span>
   <span class="font24">SARS-CoV </span>
   <span class="font24">acute </span>
   <span class="font24">al.). </span>
   <span class="font22">{border-style </span>
   <span class="font22">FcR </span>
   <span class="font21">al.; </span>
   <span class="font21">infection </span>
   <span class="font21">px;} </span>
   <span class="font20">#ffffff;} </span>
   <span class="font20">ACE </span>
   <span class="font19">severe </span>
   <span class="font18">SARS-CoV- </span>
   <span class="font18">patients </span>
   <span class="font17">coronavirus </span>
   <span class="font16">infection, </span>
   <span class="font16">inflammation </span>
   <span class="font16">injury </span>
   <span class="font16">respiratory </span>
   <span class="font15">antibodies </span>
   <span class="font15">complex </span>
   <span class="font15">pulmonary </span>
   <span class="font15">antiviral </span>
   <span class="font15">cause </span>
   <span class="font15">disease </span>
   <span class="font15">enhancement </span>
   <span class="font15">infected </span>
   <span class="font15">possible </span>
   <span class="font15">px; </span>
   <span class="font15">{font-family </span>
   <span class="font14">IgG </span>
   <span class="font14">addition, </span>
   <span class="font14">antibody </span>
   <span class="font14">block </span>
   <span class="font14">enzyme </span>
   <span class="font14">font-size </span>
   <span class="font14">injury. </span>
   <span class="font14">mechanisms </span>
   <span class="font14">neutralizing </span>
   <span class="font14">receptor </span>
   <span class="font14">replication </span>
   <span class="font14">responses. </span>
   <span class="font14">studies </span>
   <span class="font14">virus </span>
   <span class="font13">(Fig. </span>
   <span class="font13">SARS </span>
   <span class="font13">activation. </span>
   <span class="font13">double; </span>
   <span class="font13">intravenous </span>
   <span class="font13">proinflammatory </span>
   <span class="font13">protein </span>
   <span class="font13">However, </span>
   <span class="font13">IL-, </span>
   <span class="font13">animal </span>
   <span class="font13">appearance </span>
   <span class="font13">binding </span>
   <span class="font13">border-color </span>
   <span class="font13">border-width </span>
   <span class="font13">causes </span>
   <span class="font13">cytokines </span>
   <span class="font13">human </span>
   <span class="font13">leading </span>
   <span class="font13">leads </span>
   <span class="font13">likely </span>
   <span class="font13">macrophages </span>
   <span class="font13">mainly </span>
   <span class="font13">novel </span>
   <span class="font13">potential </span>
   <span class="font13">primary </span>
   <span class="font13">production </span>
   <span class="font13">shedding </span>
   <span class="font13">solid; </span>
   <span class="font13">suggesting </span>
   <span class="font13">syndrome </span>
   <span class="font13">virus-NAb </span>
   <span class="font13">{font-style </span>
   <span class="font13">{font-weight </span>
   <span class="font12">(ADE) </span>
   <span class="font12">(Haga </span>
   <span class="font12">(Liu </span>
   <span class="font12">Medical </span>
   <span class="font12">Potential </span>
   <span class="font12">SARS-CoV--induced </span>
   <span class="font12">Takada </span>
   <span class="font12">University, </span>
   <span class="font12">activation </span>
   <span class="font12">active </span>
   <span class="font12">antibody-dependent </span>
   <span class="font12">blocked </span>
   <span class="font12">bold </span>
   <span class="font12">cell </span>
   <span class="font12">clinical </span>
   <span class="font12">courier; </span>
   <span class="font12">developed </span>
   <span class="font12">em; </span>
   <span class="font12">focus </span>
   <span class="font12">function </span>
   <span class="font12">immunoglobulin </span>
   <span class="font12">increased </span>
   <span class="font12">levels </span>
   <span class="font12">mechanism </span>
   <span class="font12">persistent </span>
   <span class="font12">prevent </span>
   <span class="font12">pt;} </span>
   <span class="font12">receptors </span>
   <span class="font12">reduce </span>
   <span class="font12">remain </span>
   <span class="font12">role </span>
   <span class="font12">secondary </span>
   <span class="font12">specific </span>
   <span class="font12">therapeutic </span>
   <span class="font12">treatment </span>
   <span class="font12">trigger </span>
   <span class="font12">various </span>
   <span class="font12">vascular </span>
  </p>
 </body>
</html>
